Daniel J. Feldman

Preclinical characterization of the potential of the putative atypical antipsychotic MDL 100,907 as a potent 5-HT2A antagonist with a favorable CNS safety profile.

John H. Kehne, B M Baron, A A Carr et al. · Journal of Pharmacology and Experimental Therapeutics · 1996 · 359 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16

An Industry-wide Pulmonary Study of Men and Women Manufacturing Refractory Ceramic Fibers

Grace K. LeMasters, James E. Lockey, L. Scott Levin et al. · American Journal of Epidemiology · 1998 · 46 citations · Full text

Medicine, Preventive Medicine, Ceramics +15

Mixed D2/5-HT2 Antagonism Differentially Affects Apomorphine- and Amphetamine-Induced Stereotyped Behavior

Daniel J. Feldman · Pharmacology Biochemistry and Behavior · 1997 · 19 citations

Medicine, Neuroscience, Pharmacology +12